Using Telemedicine to Treat Opioid Use DisorderTHURSDAY, OCTOBER 11, 2018
To combat limited access to medication-assisted treatment (MAT) of opioid use disorder (OUD) in rural areas, the Drug Enforcement Administration (DEA) and U.S. Department of Health and Human Services (HHS) has developed Telemedicine and Prescribing Buprenorphine for the Treatment of Opioid Use Disorder to help clarify how clinicians can use telemedicine as a tool to expand buprenorphine-based MAT for OUD treatment under current DEA regulations. This guidance includes a clinical case example.
Recent News & Events
Follow-Up System Failures: Closing the Loop on the Diagnostic Process Part 2
99999996Our analysis of Constellation malpractice claims revealed that diagnosis-related claims are the third most frequent...
Preventing and Reducing Falls: Using senior living malpractice claim data to guide change
99999995Analyzing malpractice claim data is an excellent tool for revealing gap...
HHS Releases New Cybersecurity Practices
99999989HHS has released Health Industry Cybersecurity Practices: Managing Threats and Protecting Patients...